@article{da2a7030f74b440da96b1a470d86be7c,
title = "Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging Data",
keywords = "PLACEBO-CONTROLLED PHASE-3, RELEASE DIMETHYL FUMARATE, GASTROINTESTINAL EVENTS, OXIDATIVE STRESS, PERSISTENCE, ACTIVATION, NRF2, TOLERABILITY, HISTORY, DEFINE",
author = "L Hauer and J Sellner",
note = "Hauer: Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Christian Doppler Medical Center, Paracelsus Medical University, Salzburg, Austria",
year = "2022",
doi = "10.2147/DDDT.S236926",
language = "English",
volume = "16",
pages = "3915--3927",
journal = "DRUG DESIGN DEVELOPMENT AND THERAPY",
issn = "1177-8881",
}